SEVEN STONES – Movers and Thinkers Our team brings together science, marketing and creativity to produce evidence-based solutions • helping support medical treatment in optimising the experience and outcomes for patients and physicians • helping support the sustainability of healthcare provision
- Agency description
A creative healthcare agency of movers and thinkers
Our team brings together science, marketing and creativity to produce evidence-based solutions * helping support medical treatment in optimising the experience and outcomes for patients and physicians * helping support the sustainability of healthcare provision.
What makes us us
We’re scientists and storytellers, artists and athletes.
We are a fiercely proud collective of specialists from a broad range of backgrounds. Bringing together and sharing the experience of disparate disciplines is what helps us shake things up and generate some truly different ideas.
A perfect storm of movers and thinkers.
What we do
We accelerate the change you want to make.
We take on board what you want to say and help translate it into something your customers want, or need, to hear.
Our strategy and positioning work lay the foundation for why it matters. Our creative work helps get the message heard above everything else competing for your audience’s attention.
We don’t believe an idea should depend on a particular type of media. It should be able to live as an app, a tweet, a billboard... in your head.
We take pains over copy, because words become stories which engage our hearts and our heads. And we take as much care over design because it multiplies impact, inviting content to be read.
Who we do it for
We talk (and love) science.
We preach (and practise) exercise.
We have over 25 years’ experience working with landmark brands in healthcare. With expertise in consumer marketing and elite sports coaching, our portfolio also extends to fitness and wearable tech.
While the healthcare arena is naturally evidence-based, the lifestyle sector tends to be behaviourally led. We think there’s a lot to be said for combining both approaches.
Why we do it for ourselves
Charles Darwin, William Wordsworth, Albert Einstein, Pyotr Tchaikovsky, Friedrich Nietzsche, Charles Dickens, Nelson Mandela, Immanuel Kant ...
Forget for a moment that physical inactivity is one of the most important public health problems we face in the 21st century and consider this. Some of the world’s greatest thinkers have used regular movement to enrich their creativity.
When we engage in pursuits that require physical exertion but little thought or concentration, our attention is free to wander. It’s called transient hypofrontality. And it’s precisely the kind of mental state in which ideas mingle more freely and unusual and unexpected thoughts arise.
Movers and thinkers? It’s a no-brainer.
- Key contact
- Chloe Cooper
- Operations Director
- (+)44 (0)207 851 7500
- 2019 Agency Data
- This information was supplied or confirmed by Seven Stones. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
Latest content from Seven Stones on PMHub
- St John & St Elizabeth Hospital “Putting people first” by Seven Stones
- St John & St Elizabeth Hospital has created it’s first brand campaign for the Hospital and Hospice, bringing to life its new mantra of ‘putting people first’.
- Seven Stones wins St John & St Elizabeth Hospital advertising account
- St John & St Elizabeth Hospital has awarded its advertising account to Seven Stones.
COVID-19 Updates and Daily News
- Providers are looking at digital solutions to transform this area of healthcare...
- The power of a good story: Turn your insights into effective storytelling with data visualisation...
- AZ, Oxford University face more scrutiny over COVID-19 vaccine data
- GSK, Medicago launch phase 2/3 clinical trials of plant-derived COVID-19 vaccine
- Roche’s Xofluza pill wins FDA approval for post-exposure flu prevention
- Synairgen’s SNG001 advances into phase 3 COVID-19 trial
- UK could approve Pfizer’s COVID-19 vaccine this week
- New study identifies drugs that are safe to use in COVID-19 treatment
- Live Webinar: Artificial Intelligence for Identifying and Monitoring Cognitive Decline
- The Future of Wearable and Implantable Devices
- Designing Ethical AI and Healthcare Technologies
- Attacking COVID-19 from All Angles
- Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM
- Not waving but drowning. Reflections on data curation in the age of information overload